Company Filing History:
8 out of 64 
1 out of 1 
1 out of 126 Years Active: 2013-2017
Title: Shai Rosenwald – Innovator in Cancer Research
Introduction
Shai Rosenwald, a prominent inventor based in Nes Ziona, IL, has made significant contributions to cancer research through his innovative approaches and discoveries. With a total of 8 patents to his name, Rosenwald's work focuses on the molecular understanding of tumors and the development of targeted therapies.
Latest Patents
Two of Rosenwald's latest patents showcase his expertise in the field of oncology. The first patent, titled "MicroRNAs expression signature for determination of tumors origin," presents a groundbreaking method for classifying cancers based on the expression patterns of specific microRNAs and related nucleic acid molecules. This innovative classification system allows for improved treatment optimization and better-targeted therapies for patients.
His second recent patent, "Compositions and methods for prognosis and treatment of prostate cancer," describes new compositions and methodologies specifically aimed at prostate cancer patients. This invention highlights microRNA molecules linked to prostate cancer prognosis, enhancing the approach towards effective treatment.
Career Highlights
Throughout his career, Shai Rosenwald has worked with esteemed organizations such as Rosetta Genomics Ltd. and Tel Hashomer Medical Infrastructure and Services Ltd. His experiences in these companies have significantly contributed to his development as a leading figure in cancer research and innovation.
Collaborations
Rosenwald's accomplishments are further bolstered by meaningful collaborations with talented individuals like Nitzan Rosenfeld and Ranit Aharonov. Working alongside these professionals has allowed Rosenwald to enhance his research and refine his inventions, leading to valuable breakthroughs in cancer treatment and understanding.
Conclusion
In summary, Shai Rosenwald is a dedicated inventor whose work extends the boundaries of cancer research. His patents not only reflect his inventive and scientific prowess but also hold promise for improved patient care in oncology. With an impressive career and valuable collaborations, Rosenwald continues to contribute significantly to the field of cancer treatment innovation.